Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 668 for Cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A First-in-Human Study Of MEN2312 In Adults With Advanced Breast Cancer

    Rochester, MN

  2. Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer

    Jacksonville, FL

  4. Hyperthermic Chemotherapy For Gastric Cancer At High Risk Of Peritoneal Recurrence

    Rochester, MN

  5. A Study Of Prostate Cancer Diagnosis Virtual Reality Assistant (ViRA) In Newly Diagnosed Black Men

    Jacksonville, FL, Rochester, MN

  6. Wearable EEG Headband as a Meditation Device for Breast Cancer Survivors

    Rochester, MN

  7. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Decitabine Dose-Tolerance in Surgically Resectable HPV-Negative Head and Neck Cancer

    Jacksonville, FL

  10. Conventionally Fractionated Vs. Hypofractionated Comprehensive Nodal Irradiation For Breast Cancer Using Pencil Beam Scanning ProtonTherapy

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer